Barriers to cervical cancer screening in Guatemala: a quantitative analysis using data from the Guatemala Demographic and Health Surveys.
Cervical cancer
Healthcare barriers
Indigenous communities
Screening
Journal
International journal of public health
ISSN: 1661-8564
Titre abrégé: Int J Public Health
Pays: Switzerland
ID NLM: 101304551
Informations de publication
Date de publication:
Mar 2020
Mar 2020
Historique:
received:
08
07
2019
accepted:
02
12
2019
revised:
21
11
2019
pubmed:
16
12
2019
medline:
8
7
2020
entrez:
16
12
2019
Statut:
ppublish
Résumé
Examine the association between commonly reported barriers to health care, including discordant spoken languages between patients and providers, and reported previous cervical cancer screening. Data from the nationally representative Guatemala National Maternal and Child Health Survey from the Demographic and Health Surveys Program were used to explore associations between barriers and screening rates nationwide and in high-risk populations, such as rural and indigenous communities. Negative binomial regressions were run accounting for survey sample weights to calculate prevalence ratios. 64.0%, 57.5% and 47.5% of women reported ever screening, in the overall, indigenous, and rural populations, respectively. Overall, never screened for cervical cancer was associated with the following health barriers: needing permission, cost, distance, not wanting to go alone, and primary language not spoken by health providers, even after adjustment for age, ethnicity, and literacy. Offering screening programs alone is not enough to reduce the burden of cervical cancer in Guatemala. Measures need to be taken to reduce barriers to health care, particularly in rural areas, where screening rates are lowest.
Identifiants
pubmed: 31838575
doi: 10.1007/s00038-019-01319-9
pii: 10.1007/s00038-019-01319-9
pmc: PMC7049547
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
217-226Subventions
Organisme : NCI NIH HHS
ID : P30 CA046592
Pays : United States
Organisme : NCI NIH HHS
ID : T32 CA083654
Pays : United States
Organisme : NCI NIH HHS
ID : T32CA083654
Pays : United States
Organisme : NCI NIH HHS
ID : P30CA046592
Pays : United States
Références
Cancer Nurs. 2000 Jun;23(3):168-75
pubmed: 10851767
Int J Gynecol Cancer. 2002 Sep-Oct;12(5):475-9
pubmed: 12366665
Glob Health Sci Pract. 2014 Jul 31;2(3):307-17
pubmed: 25276590
Int J Public Health. 2018 Jun;63(5):609-619
pubmed: 29704009
Cancer Epidemiol Biomarkers Prev. 2010 Aug;19(8):1893-907
pubmed: 20647400
Rev Panam Salud Publica. 2013 Mar;33(3):174-82
pubmed: 23698136
J Med Screen. 2009;16(4):199-204
pubmed: 20054095
Prog Community Health Partnersh. 2018;12(1):45-54
pubmed: 29606692
Healthc (Amst). 2018 Jun;6(2):144-149
pubmed: 28919513
Int J Gynaecol Obstet. 2017 Jul;138 Suppl 1:63-68
pubmed: 28691331
BMJ Open. 2019 Oct 28;9(10):e029158
pubmed: 31662358
Soc Sci Med. 2005 Dec;61(12):2528-35
pubmed: 15953668
J Glob Oncol. 2018 Jul;4:1-10
pubmed: 30084698
Int J Cancer. 2019 Apr 15;144(8):1941-1953
pubmed: 30350310
Prev Med. 2004 Jul;39(1):91-8
pubmed: 15207990
Contraception. 2017 Apr;95(4):339-363
pubmed: 28025018
Contraception. 2009 Aug;80(2):108-12
pubmed: 19631784
J Glob Oncol. 2017 Jan 18;3(5):444-454
pubmed: 29094082
Lancet Oncol. 2015 Oct;16(14):1405-38
pubmed: 26522157